References
- Kyle RA, Greipp PR. Smoldering multiple myeloma. N Engl J Med. 1980;302(24):1347–1349.
- The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br J Haematol. 2003;121(5):749–757.
- Kyle RA, Remstein ED, Therneau TM, et al., Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356(25):2582–2590. .
- Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–548.
- Rheingold JJ, Kaufman R, Adelson E, et al. Smoldering acute leukemia. N Engl J Med. 1963;268:812–815.
- Dimopoulos MA, Moulopoulos LA, Maniatis A, et al. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96(6):2037–2044. .
- Alexanian R. Localized and indolent myeloma. Blood. 1980;56(3):521–525.
- Rajkumar SV, Landgren O, Mateos M-V. Smoldering multiple myeloma. Blood. 2015;125(20):3069–3075.
- Rajkumar SV. Myeloma today: disease definitions and treatment advances. Am J Hematol. 2016;91(1):90–100.
- Ghobrial IM, Landgren O. How. I treat smoldering multiple myeloma. Blood. 2014;124(23):3380–3388.
- Kumar SK. Timing of treatment of smoldering myeloma: delay until progression. Blood Adv. 2018;2(21):3050–3053. Published online 2018 Nov 13.
- Kim EB, Yee AJ, Raje N. Treatment of smoldering multiple myeloma: Ready for prime time? Cancers (Basel). 2020;12(5):1223.
- NCCN Guidelines Version 4.2020. Multiple myeloma. [cited 2020 Jul 15].
- Hjorth M, Hellquist L, Holmberg E, et al. Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I - A randomized study. Eur J Haematol. 1993;50(2):95–102.
- Riccardi A, Ucci G, Luoni R, et al. Treatment of multiple myeloma according to the extension of the disease: a prospective, randomized study comparing a less with a more aggressive cytostatic policy. Br J Cancer. 1994;70(6):1203‐1210.
- Raje N, Yee AJ. How we approach smoldering multiple myeloma. J Clin Oncol. 2020;38(11):1119–1125.
- J-A H, Martínez-López J, Lahuerta -J-J. Timing treatment for smoldering myeloma: is earlier better? Exp Rev Hematol. 2019;12(5):345–354.